Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05610852 · ClinicalTrials.gov registry record · NA

Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

A NA study of Prostate Cancer and Prostate Adenocarcinoma, sponsored by Case Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
276
Enrollment target
1
Study location

NCT05610852 is a NA study of Prostate Cancer and Prostate Adenocarcinoma that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 276 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05610852, a NA study of Prostate Cancer and Prostate Adenocarcinoma, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
276 participants
Enrollment target
1
Study location

Study Summary

This study aims to compare the novel single-port robotic partial prostatectomy to High-intensity focused ultrasound (HIFU) in patients with low to intermediate risk localized prostate cancer. These interventions have become acceptable focal therapies prevalent with beneficial oncologic outcomes and therefore need to be examined further.

Interventions

  • PROCEDURE Transvesical Single Port Robotic Partial Prostatectomy
  • PROCEDURE High-intensity focused ultrasound (HIFU)

Study Locations (1)

Ohio

  • Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center - Cleveland

Trial Details

FieldValue
Enrollment Target 276 participants
Start Date 2024-01-01
Est. Completion 2028-07-01
Phase NA

Sponsor

Case Comprehensive Cancer Center

407 total trials

What the Registry Record Tells You About NCT05610852

The ClinicalTrials.gov registry entry for NCT05610852 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (55% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Transvesical Single Port Robotic Partial Prostatectomy is the first listed.

NCT05610852 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05610852 about?

NCT05610852 is a clinical study titled "Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound". This study aims to compare the novel single-port robotic partial prostatectomy to High-intensity focused ultrasound (HIFU) in patients with low to intermediate risk localized prostate cancer. These interventions have become acceptable focal therapies prevalent with beneficial oncologic outcomes and ...

What is the current status of trial NCT05610852?

This trial is currently recruiting. It is a NA study. The enrollment target is 276 participants. The study started on 2024-01-01. Estimated completion is 2028-07-01.

What conditions does trial NCT05610852 study?

This clinical trial studies the following conditions: Prostate Cancer, Prostate Adenocarcinoma.

What interventions are being tested in trial NCT05610852?

The interventions under investigation include: Transvesical Single Port Robotic Partial Prostatectomy (PROCEDURE), High-intensity focused ultrasound (HIFU) (PROCEDURE).

Who is sponsoring clinical trial NCT05610852?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05610852 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.